GSK to resolve 1,000 Avandia lawsuits
Avandia (rosiglitazone maleate) is an oral antidiabetic agent which acts primarily by increasing insulin sensitivity. The cases were filed against GSK as studies linked the drug to increased
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Biovista expects to utilize its Clinical Outcomes Search Space (COSS) platform and multi-dimensional profiling capabilities to identify new treatments that reflect patients’ individual pathophysiological characteristics. The ‘p-medicine’ project